A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...

Cognitive impairment is common in untreated MS patients, affecting 1 in 4, with rates particularly higher in those with SPMS, ...

4 Researchers at the University of Houston recently found that high-efficacy disease-modifying agents decreased the risk of relapse in male patients with multiple sclerosis versus moderate ...

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment ...

A Blood Test Shows MS Worsening 1 to 2 Years Before It Happens Nov. 6, 2023 — Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening ...

Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...

A new report indicates that for every 1,000 U.S. employees, five autoimmune conditions drive an estimated $562,000 in excess ...

Dr Pavan Bhargava anticipates updates on diagnostic criteria, MRI techniques, biomarkers, treatments, and the role of diet in ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisIf approved, tolebrutinib would be ...

More Stamina is a gamified app that helps MS patients track and manage fatigue, improving self-awareness and daily planning.